Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | Nina Shah: highlights from EHA

Nina Shah • 8 Jun 2020
EHA 2020
Multiple Myeloma AUTO3 CAR-T
KarMMa

This year’s European Hematology Association (EHA) Virtual Meeting 2020 presented major advances in hematology, with over 3,300 abstracts submitted. In this video, Nina Shah, MD, of the University of California, San Francisco, CA, discusses key abstracts on BCMA targeting therapies presented at EHA including a correlative analysis and a quality of life analysis, both from KarMMA (NCT03361748). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Nina Shah

19:39
T-Cell Engagers: targets, challenges and opportunity
Hermann Einsele et al. • 27 Mar 2022
1:28
NKTR-255 in multiple myeloma and NHL
Nina Shah • 10 Dec 2021
2:15
Reporting patient experiences during the KarMMa trial
Nina Shah • 10 Dec 2021
2:06
Subanalysis of the KarMMa Trial: Predicting complete response to CAR-T in multiple myeloma
Nina Shah • 10 Dec 2021

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals